Published in Antimicrob Agents Chemother on January 01, 1999
Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother (1999) 7.94
Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol (2010) 6.18
Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob Agents Chemother (2001) 4.17
Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. Antimicrob Agents Chemother (1999) 2.52
Molecular detection of antimicrobial resistance. Clin Microbiol Rev (2001) 2.31
Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother (2001) 2.30
Contribution of exogenous genetic elements to the group A Streptococcus metagenome. PLoS One (2007) 2.22
Characterization of a genetic element carrying the macrolide efflux gene mef(A) in Streptococcus pneumoniae. Antimicrob Agents Chemother (2000) 2.21
Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. Antimicrob Agents Chemother (1999) 2.01
Ribosomal mutations in Streptococcus pneumoniae clinical isolates. Antimicrob Agents Chemother (2002) 1.63
Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients. Antimicrob Agents Chemother (2000) 1.57
Identification of an erm(A) erythromycin resistance methylase gene in Streptococcus pneumoniae isolated in Greece. Antimicrob Agents Chemother (2001) 1.50
Macrolide resistance genes in Enterococcus spp. Antimicrob Agents Chemother (2000) 1.48
In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors. Antimicrob Agents Chemother (2000) 1.43
Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001. Antimicrob Agents Chemother (2003) 1.34
Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain. Antimicrob Agents Chemother (2005) 1.34
Identification of the conjugative mef gene in clinical Acinetobacter junii and Neisseria gonorrhoeae isolates. Antimicrob Agents Chemother (2000) 1.29
Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci. Antimicrob Agents Chemother (2000) 1.28
In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species. Antimicrob Agents Chemother (2001) 1.27
Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital. Antimicrob Agents Chemother (2003) 1.24
Emergence of group A streptococcus strains with different mechanisms of macrolide resistance. Antimicrob Agents Chemother (2002) 1.21
High prevalence of inducible erythromycin resistance among Streptococcus bovis isolates in Taiwan. Antimicrob Agents Chemother (2001) 1.19
Prevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A streptococci in Southern Taiwan. J Clin Microbiol (2000) 1.16
Resistance determinants and clonal diversity in group A streptococci collected during a period of increasing macrolide resistance. Antimicrob Agents Chemother (2002) 1.15
Rapid inversion of the prevalences of macrolide resistance phenotypes paralleled by a diversification of T and emm types among Streptococcus pyogenes in Portugal. Antimicrob Agents Chemother (2005) 1.15
Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries. Antimicrob Agents Chemother (2002) 1.12
Serotype and genotype replacement among macrolide-resistant invasive Pneumococci in adults: mechanisms of resistance and association with different transposons. J Clin Microbiol (2010) 1.09
Clonal spread of emm type 28 isolates of Streptococcus pyogenes that are multiresistant to antibiotics. J Clin Microbiol (2004) 1.06
Molecular detection of the macrolide efflux gene: to discriminate or not to discriminate between mef(A) and mef(E). Antimicrob Agents Chemother (2005) 1.05
Macrolide resistance in Peptostreptococcus spp. mediated by ermTR: possible source of macrolide-lincosamide-streptogramin B resistance in Streptococcus pyogenes. Antimicrob Agents Chemother (2001) 1.05
Macrolide-resistant Streptococcus pyogenes in Norway: population structure and resistance determinants. Antimicrob Agents Chemother (2006) 1.04
M.SpyI, a DNA methyltransferase encoded on a mefA chimeric element, modifies the genome of Streptococcus pyogenes. J Bacteriol (2006) 1.04
Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea. Antimicrob Agents Chemother (2004) 1.01
Mutation at the position 2058 of the 23S rRNA as a cause of macrolide resistance in Streptococcus pyogenes. Ann Clin Microbiol Antimicrob (2004) 0.97
Molecular analysis of group A streptococcal isolates associated with scarlet fever in southern Taiwan between 1993 and 2002. J Clin Microbiol (2003) 0.97
New genetic element carrying the erythromycin resistance determinant erm(TR) in Streptococcus pneumoniae. Antimicrob Agents Chemother (2007) 0.97
Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes. Antimicrob Agents Chemother (2001) 0.95
Six-month multicenter study on invasive infections due to group B streptococci in Argentina. J Clin Microbiol (2003) 0.94
Antibiotic susceptibility in neonatal invasive isolates of Streptococcus agalactiae in a 2-year nationwide surveillance study in Germany. Antimicrob Agents Chemother (2004) 0.94
Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile. Antimicrob Agents Chemother (2001) 0.92
Changing molecular epidemiology of group B streptococcus in Korea. J Korean Med Sci (2010) 0.91
Mutations in 23S rRNA confer resistance against azithromycin in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2012) 0.90
In vitro antibacterial activity of modithromycin, a novel 6,11-bridged bicyclolide, against respiratory pathogens, including macrolide-resistant Gram-positive cocci. Antimicrob Agents Chemother (2011) 0.90
Serotypes and genotypes of erythromycin-resistant group B streptococci in Korea. J Clin Microbiol (2004) 0.88
Macrolide resistance determinants of invasive and noninvasive group B streptococci in a Turkish hospital. Antimicrob Agents Chemother (2004) 0.87
Genetic basis of erythromycin resistance in oral bacteria. Antimicrob Agents Chemother (2004) 0.86
Heterogeneity of macrolide-lincosamide-streptogramin B resistance phenotypes in enterococci. Antimicrob Agents Chemother (2003) 0.85
Ribosomal Resistance: Emerging Problems and Potential Solutions. Curr Infect Dis Rep (1999) 0.85
Prevalence of macrolide resistance genes in clinical isolates of the Streptococcus anginosus ("S. milleri") group. Antimicrob Agents Chemother (2001) 0.85
Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data. Antimicrob Agents Chemother (2003) 0.85
Chromosomal islands of Streptococcus pyogenes and related streptococci: molecular switches for survival and virulence. Front Cell Infect Microbiol (2014) 0.84
Molecular epidemiology, antimicrobial susceptibilities and resistance mechanisms of Streptococcus pyogenes isolates resistant to erythromycin and tetracycline in Spain (1994-2006). BMC Microbiol (2012) 0.83
Resistance phenotypes and genotypes of erythromycin-resistant Streptococcus pneumoniae isolates in Beijing and Shenyang, China. Antimicrob Agents Chemother (2004) 0.77
Conjugal transfer of plasmid-borne multiple antibiotic resistance in Streptococcus faecalis var. zymogenes. J Bacteriol (1974) 20.17
Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother (1996) 10.56
Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother (1996) 8.65
Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob Agents Chemother (1991) 7.18
Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol Microbiol (1996) 4.86
Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother (1993) 4.83
Characterization of a plasmid determining resistance to erythromycin, lincomycin, and vernamycin Balpha in a strain Streptococcus pyogenes. Antimicrob Agents Chemother (1974) 4.47
Resistance to erythromycin in group A streptococci. N Engl J Med (1992) 4.42
mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob Agents Chemother (1997) 4.38
A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob Agents Chemother (1998) 3.97
Nucleotide sequence of the erythromycin resistance gene of the conjugative transposon Tn1545. Nucleic Acids Res (1990) 3.74
Transposition of Tn554 does not generate a target duplication. Nature (1984) 2.82
Conjugative transfer of multiple-antibiotic resistance markers in beta-hemolytic group A, B, F, and G streptococci in the absence of extrachromosomal deoxyribonucleic acid. Plasmid (1981) 2.51
Inducible and constitutive resistance to macrolide antibiotics and lincomycin in clinically isolated strains of Streptococcus pyogenes. Antimicrob Agents Chemother (1973) 2.50
Different erythromycin resistance mechanisms in group C and group G streptococci. Antimicrob Agents Chemother (1998) 2.33
Evaluation of methods for epidemiologic typing of group A streptococci. J Infect Dis (1994) 1.75
Cloning and hybridization analysis of ermP, a macrolide-lincosamide-streptogramin B resistance determinant from Clostridium perfringens. Antimicrob Agents Chemother (1989) 1.67
Typing of group A streptococci by random amplified polymorphic DNA analysis. J Clin Microbiol (1994) 1.63
Cloning and characterization of a novel macrolide efflux gene, mreA, from Streptococcus agalactiae. Antimicrob Agents Chemother (1997) 1.59
Characterization of the antibiotic resistance plasmid ERL1 from Streptococcus pyogenes. Mol Gen Genet (1976) 1.57
Narrow host range of some streptococcal R plasmids. Plasmid (1982) 1.52
Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland. J Infect Dis (1997) 1.50
A community outbreak of group A beta haemolytic streptococci with transferable resistance to erythromycin. Epidemiol Infect (1989) 1.42
Conjugative R plasmids in group C and G streptococci. J Bacteriol (1981) 1.36
Clonal spread of group A streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance. J Infect Dis (1998) 1.36
Broad host range of streptococcal macrolide resistance plasmids. Antimicrob Agents Chemother (1984) 1.21
Genetic study of plasmid-associated zonal resistance to lincomycin in Streptococcus pyogenes. Antimicrob Agents Chemother (1981) 1.11
Characterization of an erythromycin resistance (erm) plasmid in Streptococcus pyogenes. APMIS (1995) 1.05
The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med (1997) 9.63
Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother (1993) 4.83
Bacterial polysaccharide synthesis and gene nomenclature. Trends Microbiol (1996) 4.49
Increased virulence of Yersinia pseudotuberculosis by two independent mutations. Nature (1988) 4.20
Antimicrobial resistance. Is a major threat to public health. BMJ (1998) 4.18
A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob Agents Chemother (1998) 3.97
Detection and identification of mycobacteria by amplification of a segment of the gene coding for the 32-kilodalton protein. J Clin Microbiol (1992) 3.62
The surface-located YopN protein is involved in calcium signal transduction in Yersinia pseudotuberculosis. Mol Microbiol (1991) 3.56
Direct amplification of rRNA genes in diagnosis of bacterial infections. J Clin Microbiol (2000) 3.02
Virulence plasmid-associated autoagglutination in Yersinia spp. J Bacteriol (1984) 3.01
Plasmids in Yersinia enterocolitica serotypes O:3 and O:9: correlation with epithelial cell adherence in vitro. Infect Immun (1981) 2.85
Comparison of polymerase chain reaction with culture and enzyme immunoassay for diagnosis of pertussis. J Clin Microbiol (1993) 2.41
Plasmid-mediated surface fibrillae of Yersinia pseudotuberculosis and Yersinia enterocolitica: relationship to the outer membrane protein YOP1 and possible importance for pathogenesis. Infect Immun (1987) 2.40
Binding to collagen by Yersinia enterocolitica and Yersinia pseudotuberculosis: evidence for yopA-mediated and chromosomally encoded mechanisms. J Bacteriol (1989) 2.36
Different erythromycin resistance mechanisms in group C and group G streptococci. Antimicrob Agents Chemother (1998) 2.33
Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test. J Clin Microbiol (1999) 2.33
Application of the polymerase chain reaction and immunofluorescence techniques to the detection of bacteria in Yersinia-triggered reactive arthritis. Arthritis Rheum (1991) 2.18
Hydrophobic domains affect the collagen-binding specificity and surface polymerization as well as the virulence potential of the YadA protein of Yersinia enterocolitica. Mol Microbiol (1993) 2.13
Use of the polymerase chain reaction and DNA sequencing for detection of Bartonella quintana in the aortic valve of a patient with culture-negative infective endocarditis. Clin Infect Dis (1995) 2.07
YadA, the multifaceted Yersinia adhesin. Int J Med Microbiol (2001) 2.00
The lcrE gene is part of an operon in the lcr region of Yersinia enterocolitica O:3. J Bacteriol (1990) 1.94
Identification and mapping of the temperature-inducible, plasmid-encoded proteins of Yersinia spp. Infect Immun (1988) 1.90
Bacteriophage phiYeO3-12, specific for Yersinia enterocolitica serotype O:3, is related to coliphages T3 and T7. J Bacteriol (2000) 1.83
katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients. Antimicrob Agents Chemother (1996) 1.82
Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerg Infect Dis (2001) 1.78
Evaluation of methods for epidemiologic typing of group A streptococci. J Infect Dis (1994) 1.75
Adhesion protein YadA of Yersinia species mediates binding of bacteria to fibronectin. Infect Immun (1992) 1.66
Outbreak of diarrhoea due to Escherichia coli O111:B4 in schoolchildren and adults: association of Vi antigen-like reactivity. Lancet (1990) 1.65
Expression of antigens encoded by the virulence plasmid of Yersinia enterocolitica under different growth conditions. Infect Immun (1985) 1.64
Typing of group A streptococci by random amplified polymorphic DNA analysis. J Clin Microbiol (1994) 1.63
Genetic organization and sequence of the rfb gene cluster of Yersinia enterocolitica serotype O:3: similarities to the dTDP-L-rhamnose biosynthesis pathway of Salmonella and to the bacterial polysaccharide transport systems. Mol Microbiol (1993) 1.62
Molecular and chemical characterization of the lipopolysaccharide O-antigen and its role in the virulence of Yersinia enterocolitica serotype O:8. Mol Microbiol (1997) 1.62
Functional mapping of the Yersinia enterocolitica adhesin YadA. Identification Of eight NSVAIG - S motifs in the amino-terminal half of the protein involved in collagen binding. Mol Microbiol (2000) 1.55
A novel dihydrofolate reductase cassette inserted in an integron borne on a Tn21-like element. Antimicrob Agents Chemother (1993) 1.51
Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland. J Infect Dis (1997) 1.50
Lack of correlation between the presence of plasmids and fimbriae in Yersinia enterocolitica and Yersinia pseudotuberculosis. J Appl Bacteriol (1984) 1.49
Control of antimicrobial resistance: time for action. The essentials of control are already well known. BMJ (1998) 1.48
Antibiotic resistance. How wild are wild mammals? Nature (2001) 1.48
Bacterial 16S rDNA polymerase chain reaction in the detection of intra-amniotic infection. Br J Obstet Gynaecol (1996) 1.48
Guideline for the management of acute sore throat. Clin Microbiol Infect (2012) 1.48
Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin Infect Dis (1995) 1.43
In vitro activity of a new cyclic lipopeptide antibiotic, LY146032, against gram-positive clinical bacteria. Antimicrob Agents Chemother (1987) 1.41
Clonal spread of group A streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance. J Infect Dis (1998) 1.36
Evaluation of five different methods to prepare bacterial extracts for the identification of beta-lactamases by isoelectric focusing. J Antimicrob Chemother (1993) 1.34
A between-species comparison of antimicrobial resistance in enterobacteria in fecal flora. Antimicrob Agents Chemother (2000) 1.33
A synthetic oligonucleotide probe and a cloned polynucleotide probe based on the yopA gene for detection and enumeration of virulent Yersinia enterocolitica. Appl Environ Microbiol (1990) 1.33
Complete genomic sequence of the lytic bacteriophage phiYeO3-12 of Yersinia enterocolitica serotype O:3. J Bacteriol (2001) 1.30
Increase of trimethoprim resistance among Shigella species, 1975-1988: analysis of resistance mechanisms. J Infect Dis (1990) 1.29
Simultaneous real-time PCR detection of Bacillus anthracis, Francisella tularensis and Yersinia pestis. Eur J Clin Microbiol Infect Dis (2007) 1.27
Application of gas-liquid chromatographic analysis of cellular fatty acids for species identification and typing of coagulase-negative staphylococci. J Clin Microbiol (1991) 1.27
In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species. Antimicrob Agents Chemother (2001) 1.27
Increasing fluoroquinolone resistance in salmonella serotypes in Finland during 1995-1997. J Antimicrob Chemother (1999) 1.24
Development of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993. Clin Infect Dis (1995) 1.22
Expression cloning of Yersinia enterocolitica O:3 rfb gene cluster in Escherichia coli K12. Microb Pathog (1991) 1.21
Survey of condition-based prescribing of antimicrobial drugs for dogs at a veterinary teaching hospital. Vet Rec (2004) 1.21
Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice. Diabetologia (2011) 1.20
Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin. J Infect Dis (1990) 1.20
Epidemiology of plasmid-mediated beta-lactamases in enterobacteria Swedish neonatal wards and relation to antimicrobial therapy. Antimicrob Agents Chemother (1992) 1.20
Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents. Clin Infect Dis (2001) 1.19
Yersinia-triggered reactive arthritis. Use of polymerase chain reaction and immunocytochemical staining in the detection of bacterial components from synovial specimens. Arthritis Rheum (1992) 1.19
Erythromycin resistance genes in group A streptococci of different geographical origins. The Macrolide Resistance Study Group. J Antimicrob Chemother (2000) 1.19
Interactions between Yersinia enterocolitica and rabbit ileal mucus: growth, adhesion, penetration, and subsequent changes in surface hydrophobicity and ability to adhere to ileal brush border membrane vesicles. Infect Immun (1991) 1.18
Lipopolysaccharide O side chain of Yersinia enterocolitica O:3 is an essential virulence factor in an orally infected murine model. Infect Immun (1992) 1.18
Antimicrobial susceptibility of Enterobacteriaceae isolated from vegetables. J Antimicrob Chemother (1999) 1.17
Trimethoprim resistance in Finland after five years' use of plain trimethoprim. Br Med J (1980) 1.16
Pneumonia in childhood: etiology and response to antimicrobial therapy. Eur J Clin Microbiol Infect Dis (1992) 1.14
The effect of growth temperature on the biosynthesis of Yersinia enterocolitica O:3 lipopolysaccharide: temperature regulates the transcription of the rfb but not of the rfa region. Microb Pathog (1991) 1.13
Temperature-regulated efflux pump/potassium antiporter system mediates resistance to cationic antimicrobial peptides in Yersinia. Mol Microbiol (2000) 1.12
Characterization of trimethoprim resistance by use of probes specific for transposon Tn7. Antimicrob Agents Chemother (1984) 1.10
Detection of herpesviruses by polymerase chain reaction in lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum (1993) 1.10
Role of YadA-mediated collagen binding in arthritogenicity of Yersinia enterocolitica serotype O:8: experimental studies with rats. Infect Immun (1995) 1.09
Role of the Yersinia outer membrane protein YadA in adhesion to rabbit intestinal tissue and rabbit intestinal brush border membrane vesicles. APMIS (1991) 1.07
Functional expression of adhesive peptides as fusions to Escherichia coli flagellin. Protein Eng (1997) 1.07
Rapid detection of rifampin-resistant Mycobacterium tuberculosis by sequencing and line probe assay. Scand J Infect Dis (1998) 1.07
In vitro susceptibility of Streptococcus mutans to chlorhexidine and six other antimicrobial agents. Antimicrob Agents Chemother (1993) 1.06
Analysis of genetic localization of the type I trimethoprim resistance gene from Escherichia coli isolated in Finland. Antimicrob Agents Chemother (1991) 1.06
Aminoglycoside resistance among blood culture isolates. J Clin Microbiol (1984) 1.05
Bacteriotherapy: the time has come. BMJ (2001) 1.03
Does parvovirus B19 have a role in rheumatoid arthritis? Ann Rheum Dis (1994) 1.03
Genetic evidence that the yopA gene-encoded Yersinia outer membrane protein Yop1 mediates inhibition of the anti-invasive effect of interferon. Infect Immun (1990) 1.02
The emergence and mechanisms of trimethoprim resistance in Escherichia coli isolated from outpatients in Finland. J Antimicrob Chemother (1990) 1.01
Role of YadA in arthritogenicity of Yersinia enterocolitica serotype O:8: experimental studies with rats. Infect Immun (1994) 1.01
Experimental intestinal infection of rats by Yersinia enterocolitica 0:3. A follow-up study with specific antibodies to the virulence plasmid specified antigens. Scand J Infect Dis (1986) 1.00
Construction of urease-negative mutants of Yersinia enterocolitica serotypes O:3 and o:8: role of urease in virulence and arthritogenicity. Infect Immun (2000) 1.00
Dental amalgam fillings and the amount of organic mercury in human saliva. Caries Res (2001) 0.99
Erythromycin resistance in group A streptococci. Lancet (1989) 0.99
Comparative study of a DNA hybridization method and two isolation procedures for detection of Yersinia enterocolitica O:3 in naturally contaminated pork products. Appl Environ Microbiol (1991) 0.98
Antibiotic use by indication: a basis for active antibiotic policy in the community. Scand J Infect Dis (2001) 0.97
Streptococcus pneumoniae isolates resistant to telithromycin. Antimicrob Agents Chemother (2006) 0.95
Bacterial PCR in the diagnosis of joint infection. Ann Rheum Dis (2001) 0.95